Stock listing

Ascelia Pharma Ab

Selected listing: ACES · AQUISEU · SEK · GB

Ascelia Pharma Ab (Aquis:ACES), Health Technology. Latest release Sep 24, 2026: Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal…

ACES:AQUISEUSEKGBUpdated October 3, 2026
Ascelia Pharma Ab logo
Ticker
Aquis:ACES
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Aquis
Currency
SEK

Latest news from Ascelia Pharma Ab

Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging

September 24, 2026

Ascelia Pharma Completes FDA Type A Meeting on Orviglance NDA

September 10, 2026

Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026

August 17, 2026

Ascelia Pharma Announces Organizational Changes and a Reduced Cost Base

July 15, 2026

Ascelia Pharma Provides Update on the Orviglance NDA

July 3, 2026

All Ascelia Pharma Ab news →

Events

Replays

  • Ascelia Pharma AB (publ) (ACE) Q2 2026 Earnings Call

    Thu, Aug 20, 2026 · 04:00 AM ET

    Watch

  • Ascelia Pharma AB (publ) (ACE) Q1 2026 Earnings Call

    Tue, May 12, 2026 · 04:00 AM ET

    Watch

  • Ascelia Pharma AB (publ) (ACE) Q4 2025 Earnings Call

    Thu, Feb 05, 2026 · 04:00 AM ET

    Watch

Research Ascelia Pharma Ab

Ascelia Pharma Ab company profile

View the public company page for Ascelia Pharma Ab on 6ix.

Ascelia Pharma Ab news

Read company news and market updates connected to Ascelia Pharma Ab.

Ascelia Pharma Ab investor events

Find investor webinars, events, and replay context for Ascelia Pharma Ab.

Alternate listings

ACE:OMXSTO

SE · SEK

Alternate listing for Ascelia Pharma Ab; the primary context on this page is ACES:AQUISEU.

ACES:AQUISUK

GB · SEK

Alternate listing for Ascelia Pharma Ab; the primary context on this page is ACES:AQUISEU.

7ZA:FWB

DE · EUR

Alternate listing for Ascelia Pharma Ab; the primary context on this page is ACES:AQUISEU.